BLS.AX ASX
BLS Pharmaceuticals Limited
1W: -1.0%
1M: -8.1%
YTD: +5.2%
A$1.01 ($0.70)
-0.01 (-0.98%)
Weekly Expected Move ±9.0%
A$1
A$1
A$1
A$1
A$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market CapA$233.7M ($162.5M)
52W Range0.33-1.3
Volume33,148
Avg Volume334,311
Beta0.65
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSam Watson
SectorIndustrials
IndustrySpecialty Business Services
IPO Date2000-12-12
Websiteblspharma.com
Level 5
Sydney, NSW 2000
AU
Sydney, NSW 2000
AU
About BLS Pharmaceuticals Limited
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
Latest News
No recent news
Recent Insider Trades
No insider trades found